Formulation of calcium phosphates/poly (d,l-lactide) blends containing gentamicin for bone implantation.

Implants to prevent or treat osteomyelitis are described, composed of phosphate/poly(d,l-lactide) blends containing the antibiotic gentamicin. Seven formulations of implants containing 3% gentamicin sulfate (GS) were prepared at 433 MPa and 693 MPa of compression pressure. The blends contained phosphates (25% hydroxyapatite (HAP), 75% tricalcium phosphate (TCP)) and 20% dl-PLA (weight average molecular weight, M(w): 30 kD). To prolong GS release, implants were coated with PLGA (M(w):100 kD) or dl-PLA (M(w): 200 kD). Various durations of GS release from these devices were demonstrated as feasible. Release times of more than 10 weeks were attained with implants coated with dl-PLA (M(w): 200 kD), greatly exceeding the performance of the commercial formulation.

[1]  G S Banker,et al.  Determination of porosity and pore-size distribution of aspirin tablets relevant to drug stability. , 1977, Journal of pharmaceutical sciences.

[2]  N. Araki,et al.  Calcium hydroxyapatite ceramic used as a delivery system for antibiotics. , 1992, The Journal of bone and joint surgery. British volume.

[3]  K. Garvin,et al.  Preparation and characterization of biodegradable poly(l-lactic acid) gentamicin delivery systems , 1992 .

[4]  David R. Pichora,et al.  A mechanistic study of antibiotic release from biodegradable poly(d,1-lactide) cylinders , 1994 .

[5]  M. Vert,et al.  Gentamycin/poly (lactic acid) blends aimed at sustained release local antibiotic therapy administered per-operatively. III. The case of gentamycin sulfate in films prepared from high and low molecular weight poly (DL-lactic acids) , 1993 .

[6]  W. Tong,et al.  Osteogenesis in extraskeletally implanted porous calcium phosphate ceramics: variability among different kinds of animals. , 1996, Biomaterials.

[7]  Y. Ikada,et al.  A bioabsorbable delivery system for antibiotic treatment of osteomyelitis. The use of lactic acid oligomer as a carrier. , 1991, The Journal of bone and joint surgery. British volume.

[8]  G. Cathelineau,et al.  Phosphate tricalcique, vecteur d'antibiotiques: étude sur foyer d'ostéomyélite expérimentale chez le lapin , 1998 .

[9]  N. Araki,et al.  Experimental implant-related osteomyelitis treated by antibiotic-calcium hydroxyapatite ceramic composites. , 1993, The Journal of bone and joint surgery. British volume.

[10]  T. Yotsuyanagi,et al.  Synthesis of antibiotic-loaded hydroxyapatite beads and in vitro drug release testing. , 1992, Journal of biomedical materials research.

[11]  K. Thoma,et al.  Biodegradable controlled release implants based on β-tricalcium phosphate ceramic. II: Testing of gentamicin controlled release pellets in vitro and in vivo , 1992 .

[12]  Bajpai Pk,et al.  A ceramic system for continuous release of acetylsalicylic acid. , 1994 .

[13]  B. Nies,et al.  Antibiotic in vivo/in vitro release, histocompatibility and biodegradation of gentamicin implants based on lactic acid polymers and copolymers , 1995 .

[14]  M. Vert,et al.  Gentamycin/poly(lactic acid) blends aimed at sustained release local antibiotic therapy administered per-operatively. I. The case of gentamycin base and gentamycin sulfate in poly(dl-lactic acid) oligomers , 1993 .

[15]  M. Cormier,et al.  Comparative Study of Gentamicin Release from Normal and Low Viscosity Acrylic Bone Cement , 1990, Clinical pharmacokinetics.

[16]  C. Wolf,et al.  Molecular mechanisms of drug resistance. , 1990, The Biochemical journal.

[17]  H. Aoki,et al.  Application of hydroxyapatite-sol as drug carrier. , 1994, Bio-medical materials and engineering.

[18]  J. Calhoun,et al.  Treatment of Osteomyelitis With a Biodegradable Antibiotic Implant , 1997, Clinical orthopaedics and related research.

[19]  M. Vert,et al.  Gentamycin/poly(lactic acid) blends aimed at sustained release local antibiotic therapy administered per-operatively. II. The case of gentamycin sulfate in high molecular weight poly(dl-lactic acid) and poly(l-lactic acid) , 1993 .

[20]  K. Thoma,et al.  Biodegradable controlled release implants based on β-tricalcium phosphate ceramic. I: Preparation and characterization of porous β-tricalcium phosphate ceramic pellets , 1992 .

[21]  M. Pankaskie,et al.  The influence of manufacturing procedure on the degradation of poly(lactide-co-glycolide) 85:15 and 50:50 implants , 1997 .

[22]  G. Alderborn,et al.  Compression characteristics of granulated materials. VI: Pore size distributions, assessed by mercury penetration, of compacts of two lactose granulations with different fragmentation propensities , 1992 .

[23]  F. Langlais,et al.  [Antibiotic release by tricalcic phosphate bone implantation. In vitro and in vivo pharmacokinetics of different galenic forms]. , 1997, Chirurgie; memoires de l'Academie de chirurgie.

[24]  D. Pichora,et al.  Biodegradable Controlled Antibiotic Release Devices for Osteomyelitis: Optimization of Release Properties , 1994, The Journal of pharmacy and pharmacology.

[25]  George Zografi,et al.  Sorption of Water by Solids , 1995 .